net. Diese α-Version wurde Stapesplasty Background. Otosclerosis aﬀects health- Results. The SPOT-25 showed a high internal Outcome Test 47 (SPOT-47; . Tab. 1) related quality of life (HRQOL). Until now, consistency (Cronbach’s α > 0.7), allowed genannt. measurements have only been performed discrimination between otosclerosis patients Die statistische Auswertung erfolgte using audiometric data or non-validated and healthy subjects, and demonstrated quality of life questionnaires. acceptable test–retest reliability (r = 0.85). mit der Statistiksowa ft re JMP 5.1. (SAS Objective. The objective of this study was to After stapes surgery, the HRQOL improved Institute, Cary, NC, USA). develop the ﬁrst validated disease-speciﬁc signiﬁcantly. The responsiveness was high. Zur Itembewertung und Itemreduk- HRQOL measuring instrument to determine Conclusion. TheSPOT-25 is theﬁrst validated tion erfolgte eine sequenzielle statisti- HRQOL in otosclerosis. disease-speciﬁc instrument for HRQOL sche Analyse. Diese enthielt eine Einzel- Materials and methods. After sequential measurement in otosclerosis patients. It analysis and item reduction of the initial should be used routinely for quality control. itemanalyse,eineBewertungderinternen Stapesplasty Outcome Test 47 (SPOT-47), Konsistenz, der Konstruktvalidität und the SPOT-25 was validated prospectively on Keywords der Divergenzvalidität. Da sich im Sha- 52 otosclerosis patients undergoing stapes Patient-reported Outcomes · Outcome piro-Wilk-Test keine Normalverteilung surgery. In
HNO – Springer Journals
Published: Jul 17, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera